12 results about "Injections insulin" patented technology

The application discloses a kind of sterile insulin injection devices for diabetic patients in the field of insulin injection, including two the installation frame mutually close one side upper portion It is provided with side support on each, it is provided with middle support between two side supports, the left and right ends of the middle support are connected with corresponding side support respectively via a height adjusting assembly, it is provided with the movable seat that can move transversely on the middle support, it is provided with the injection positioning mechanism that can swing position forward and backward on the movable seat, the injector is installed on the injection positioning mechanism;The outside of two the installation frame is connected with several transverse coupling belts, the outward end of each coupling belt on left side is fixed with fixed part one, the outward end of each coupling belt on right side is fixed with fixed part two.The application can realize sterile insulin injection, avoid the infection of injection site caused by non-standard operation.

1. The name of the design product: insulin pump. 2. The use of the design product: for patients to inject insulin. 3. The design features of the design product: in shape. 4. The picture or photo that best shows the design features: perspective view.

Systems and methods are disclosed for managing a person's blood glucose concentration within a predetermined range by co-administration of insulin and pramlintide using an automated insulin delivery system. A model predictive control (MPC) algorithm that includes a glucoregulatory control model augmented with a compartment model of pramlintide pharmacokinetics and pharmacodynamics is utilized. In some embodiments, the person may announce in advance meals to be consumed and the pramlintide-aware MPC algorithm uses this data as input to the glucoregulatory control model. In other embodiments, an automatic meal detection and size estimation algorithm is incorporated into the system to relieve the person of the burden of meal entry and carbohydrate estimation.

The present application relates to the technical field of insulin injection, in particular to a moon phase insulin syringe, which comprises a syringe body, a protective cover, a connecting chuck, a connecting clasp, a connecting ring, a connecting threaded ring, a connecting threaded groove, a connecting head and a needle, the connecting chuck is fixedly connected at the bottom of the syringe body, the connecting clasp is fixedly connected at the bottom end of the connecting chuck, the protective cover is clamped and fixedly connected at the bottom end of the connecting chuck through the connecting clasp, the connecting threaded ring is fixedly connected at the middle of the bottom end of the syringe body, the connecting ring is fixedly connected at the bottom end of the connecting chuck, the connecting threaded ring is located inside the connecting ring, and the connecting threaded groove is arranged between the connecting threaded ring and the connecting ring. The connecting adjusting part and the stamping part can leave a decorative pattern around the injection needle hole during the process of inserting the needle into the skin to inject insulin, the pattern can shield the needle hole, and the position and the number of needle pricking can be known by observing the pattern.

A method, system, and computer-readable medium are provided for a dual mode Closed-Loop Control (CLC) system integrating each of (i) an adaptive, personalized Model Predictive Control (MPC) control law that modulates the control strength of insulin infusion depending on recent past control actions, glucose measurements, and their derivative(s), (ii) an automatic Bolus Priming System (BPS) that commands additional insulin injections upon the detection of enabling metabolic conditions (e.g., an unannounced meal), and (iii) a hyperglycemia mitigation system (HMS) to avoid prevailing hyperglycemia.

1. Name of the product in this design: Insulin Pump. 2. Purpose of this design: For use in injecting insulin into patients. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D rendering 2.

The utility model discloses an automatic insulin needle taking and unloading device, and relates to the technical field of medical instruments. The expansion groove is formed in the inner wall of the lower part of the shell; the extrusion groove is formed in the inner wall of the upper part of the shell; the elastic inner cylinder is in threaded connection with the interior of the shell, and an expansion joint is formed in the upper portion of the elastic inner cylinder; the rubber pads are symmetrically and fixedly connected to the inner ring face of the upper portion of the elastic inner cylinder, the number of the rubber pads is not less than two, and the purpose of automatically collecting insulin needles is achieved by enabling the needles spirally detached from an insulin pen to fall to the bottommost portion of the elastic inner cylinder. The tedious steps of manually detaching the needle from the insulin pen in the prior art and rotationally screwing off the needle and discarding the needle into an appointed garbage can in the prior art are avoided, and the effects of continuously injecting insulin into different patients and quickly taking down and collecting the needle are achieved.

1. The name of the design product: insulin pump (B230). 2. The use of the design product: for injecting insulin. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: design 1 front view. 5. Design 1 is designated as the basic design.

1. Name of the product in this design: Insulin Pump (for Endocrinology Department). 2. Purpose of this design: For use in insulin pumps to inject insulin. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

The present disclosure describes a method, device and medium for detecting insulin leakage, which comprises: after a patient injects insulin, using an adsorption material to adsorb the insulin leakage at a target position related to the amount of insulin leakage, and collecting an image of the adsorption material with the adsorbed insulin leakage to obtain a leakage image; performing contrast enhancement on the leakage image to obtain an enhanced image; performing binary classification based on the pixels in the enhanced image to obtain two categories of pixels; selecting target category pixels from the two categories of pixels based on a first gray interval before the adsorption material adsorbs insulin and a second gray interval after the adsorption material adsorbs insulin; performing convex hull fitting on the region corresponding to the target category pixels to determine a leakage region; determining a leakage area based on the resolution of the leakage image and the leakage region; and determining the amount of insulin leakage corresponding to the leakage area based on the adsorption capacity and the leakage area. Thus, the amount of insulin leakage can be effectively, conveniently and non-invasively obtained.

1. The name of the design product: insulin pump. 2. The use of the design product: for injecting insulin. 3. The design features of the design product: in the overall shape. 4. The picture or photograph best indicating the design features: perspective view 1.

The present disclosure describes an analysis method and system for blood glucose fluctuation caused by insulin leakage adsorbed by an NC membrane, the method comprising collecting a leakage image, adsorbing leakage at a target position by a nitrocellulose membrane after a patient injects insulin, and taking a picture of the nitrocellulose membrane after adsorption of the leakage and a reference object to obtain a leakage image; analyzing the leakage image to determine a leakage area in the leakage image; determining a leakage area based on a resolution of the leakage image, the leakage area, and a reference object pattern; determining a leakage volume corresponding to the leakage area based on an adsorption capacity of the nitrocellulose membrane and the leakage area; and determining an impact of the leakage volume on blood glucose fluctuation of the patient based on an injection dose, the leakage volume, a first blood glucose level and a second blood glucose level of the patient, the first blood glucose level and the second blood glucose level being blood glucose indicators before and after the patient injects insulin, respectively. Thus, the leakage volume can be effectively, conveniently and non-invasively obtained to analyze the impact of the leakage volume on blood glucose fluctuation.